We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
18 Mar 2021 - 21 Mar 2021
13 Apr 2021 - 16 Apr 2021

Next Generation Automation Solution Exhibited at AACC

By Christina Chang, LabMedica Regional Director
Posted on 18 Jul 2012
Print article
AACC 2012: A new, adaptable automation solution allows a phased implementation to accommodate both current and future needs of medium- to very high-volume laboratories. The solution was unveiled at the 2012 annual meeting of the AACC and ASCLS and Clinical Lab Expo in Los Angeles (CA, USA) on July 15–19, 2012.

The circular track and modular design ensure Siemens Aptio Automation solution can adapt to nearly any lab or testing environment. It also offers connectivity to Siemens’ (Munich, Germany) portfolio of automation-ready analyzers, facilitating a multidisciplinary approach to testing. In addition, Aptio Automation’s point-in-space aspiration feature helps workflow by reducing the need to aliquot samples, and its puck-based system with Radio-frequency identification (RFID) enables individual sample routing and tracking, along with STAT prioritization.

William Bartlett, PhD, Joint Clinical Director of Diagnostics at the UK’s NHS Tayside (Dundee, United Kingdom) one of the first laboratories to deploy Aptio Automation, said: “We chose Aptio Automation because it can handle increasing workloads while enabling us to use our staff better. We expect that the implementation of this new platform will allow us to provide a state-of-the-art service that aligns the lab function with Tayside’s overall goals for organizational sustainability and improved patient outcomes.”

Today clinical laboratories are turning to automation to help them meet the growing demand for in vitro diagnostic testing as the labor force declines. And, these trends are only expected to continue, as approximately 17 % of laboratory professionals are anticipated to retire in the next five years. Aptio Automation is an adaptable solution that allows for a phased implementation to accommodate both current and future needs of labs.

Related Links:
NHS Tayside

Gold Supplier
Coronavirus Array
Extended Coronavirus Array
SARS-CoV-2 Antigen Test
ESPLINE SARS-CoV-2 Antigen Test
SARS-CoV-2 Nucleic Acid Detection Kit
SARS-CoV-2 Nucleic Acid Detection Kit
Gold Supplier
SARS-CoV-2 Assay

Print article


Molecular Diagnostics

view channel
Image: Histopathologic image from a patient with Li Fraumeni syndrome showing accumulation of mutant TP53 in tumoral cells (Photo courtesy of Thierry Soussi, PhD).

Clinical Germline Testing Evaluated for Pediatric Cancer Patients

Pediatric cancer is rare, with fewer than 10,000 solid tumors diagnosed in children annually in the USA. Previous studies interrogating germline predisposition broadly across pediatric cancer types have... Read more


view channel

Mindray and Tencent AI Lab to Jointly Develop AI Products for Blood Disease Screening and In Vitro Diagnosis

Shenzhen Mindray Biomedical Electronics Co., Ltd. (Shenzhen, China) has signed an AI cooperation framework agreement with Tencent AI Lab (Shenzhen, China) to jointly develop AI products for blood cell... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.